ArticleClinical ophthalmology (Auckland, N.Z.)2019

Twelve-week dosing with Aflibercept in the treatment of neovascular age-related macular degeneration.

Justus G GarwegPubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.